Drug therapy - Coronary-artery stents

被引：514

作者：

Serruys, PW ^{[1
]}

Kutryk, MJB

Ong, ATL

机构：

[1] Erasmus MC, Thoraxctr, Dept Intervent Cardiol, NL-3015 GD Rotterdam, Netherlands

[2] Univ Toronto, St Michaels Hosp, Toronto, ON M5B 1W8, Canada

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2006年 / 354卷 / 05期

关键词：

D O I：

10.1056/NEJMra051091

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

At present, 90 to 95 percent of percutaneous coronary interventions involve the implantation of a stent, often a drug-eluting stent, though most published data originated in the era of bare-metal stents. This article reviews the indications for and biology of coronary-artery stents, focusing on recent advances in drug-eluting stents. Copyright © 2006 Massachusetts Medical Society.

引用

页码：483 / 495

页数：13

共 91 条

[1] AGOSTONI P, IN PRESS AM HEART J
[2] A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction
Andersen, HR
Nielsen, TT
Rasmussen, K
Thuesen, L
Kelbaek, H
Thayssen, P
Abildgaard, U
Pedersen, F
Madsen, JK
Grande, P
Villadsen, AB
Krusell, LR
Haghfelt, T
Lomholt, P
Husted, SE
Vigholt, E
Kjaergard, HK
Mortensen, LS
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (08) : 733 - 742
[3] Endothelial progenitor cell capture by stents coated with antibody against CD34 - The HEALING-FIM (healthy endothelial accelerated lining inhibits neointimal growth-first in man) registry
Aoki, J
Serruys, PW
van Beusekom, H
Ong, ATL
McFadden, EP
Sianos, G
van der Giessen, WJ
Regar, E
de Feyter, PJ
Davis, HR
Rowland, S
Kutryk, MJB
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (10) : 1574 - 1579
[4] Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts
Baim, DS
Wahr, D
George, B
Leon, MB
Greenberg, J
Cutlip, DE
Kaya, U
Popma, JJ
Ho, KKL
Kuntz, RE
[J]. CIRCULATION, 2002, 105 (11) : 1285 - 1290
[5] Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting - The Clopidogrel Aspirin Stent International Cooperative Study (CLASSICS)
Bertrand, ME
Rupprecht, HJ
Urban, P
Gershlick, AH
[J]. CIRCULATION, 2000, 102 (06) : 624 - 629
[6] Evidence for use of coronary Stents - A hierarchical Bayesian meta-analysis
Brophy, JM
Belisle, P
Joseph, L
[J]. ANNALS OF INTERNAL MEDICINE, 2003, 138 (10) : 777 - 786
[7] Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model
Carter, AJ
Aggarwal, M
Kopia, GA
Tio, F
Tsao, PS
Kolata, R
Yeung, AC
Llanos, G
Dooley, L
Falotico, R
[J]. CARDIOVASCULAR RESEARCH, 2004, 63 (04) : 617 - 624
[8] Early and mid-term results of drug-eluting dtent implantation in unprotected left main
Chieffo, A
Stankovic, G
Bonizzoni, E
Tsagalou, E
Iakovou, I
Montorfano, M
Airoldi, F
Michev, I
Sangiorgi, MG
Carlino, M
Vitrella, G
Colombo, A
[J]. CIRCULATION, 2005, 111 (06) : 791 - 795
[9] Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions
Colombo, A
Drzewiecki, J
Banning, A
Grube, E
Hauptmann, K
Silber, S
Dudek, D
Fort, S
Schiele, F
Zmudka, K
Guagliumi, G
Russell, ME
[J]. CIRCULATION, 2003, 108 (07) : 788 - 794
[10] Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions
Colombo, A
Moses, JW
Morice, MC
Ludwig, J
Holmes, DR
Spanos, V
Louvard, Y
Desmedt, B
Di Mario, C
Leon, MB
[J]. CIRCULATION, 2004, 109 (10) : 1244 - 1249

← 1 2 3 4 5 6 7 8 9 10 →